Climate, human behaviour or environment: individual-based modelling of Campylobacter seasonality and strategies to reduce disease burden
暂无分享,去创建一个
P. Diggle | D. Rigby | N. Williams | R. Sanderson | I. Lake | S. Rushton | M. Shirley | W. Reid | P. Hunter | S. O'Brien | N. Strachan | K. Forbes | N. Jones | J. Hardstaff | James A Maas | A. Blain | T. Humphrey
[1] John-Arne Røttingen,et al. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study , 2018, The Lancet Global Health.
[2] M. Prouty,et al. Evaluation of a conjugate vaccine platform against enterotoxigenic Escherichia coli (ETEC), Campylobacter jejuni and Shigella. , 2018, Vaccine.
[3] D. Sack,et al. Campylobacter jejuni transcriptional and genetic adaptation during human infection , 2018, Nature Microbiology.
[4] P. Teunis,et al. Acute illness from Campylobacter jejuni may require high doses while infection occurs at low doses. , 2018, Epidemics.
[5] R. Sanderson,et al. Spatio-temporal models to determine association between Campylobacter cases and environment , 2017, International journal of epidemiology.
[6] X. Didelot,et al. A combined case-control and molecular source attribution study of human Campylobacter infections in Germany, 2011–2014 , 2017, Scientific Reports.
[7] D. Rigby,et al. Novel Sampling Method for Assessing Human-Pathogen Interactions in the Natural Environment Using Boot Socks and Citizen Scientists, with Application to Campylobacter Seasonality , 2017, Applied and Environmental Microbiology.
[8] T. J. Johnson,et al. Current and Potential Treatments for Reducing Campylobacter Colonization in Animal Hosts and Disease in Humans , 2017, Front. Microbiol..
[9] P. Guerry,et al. Status of vaccine research and development for Campylobacter jejuni. , 2016, Vaccine.
[10] R. W. Hansen,et al. Innovation in the pharmaceutical industry: New estimates of R&D costs. , 2016, Journal of health economics.
[11] J. Mossong,et al. Human Campylobacteriosis in Luxembourg, 2010–2013: A Case-Control Study Combined with Multilocus Sequence Typing for Source Attribution and Risk Factor Analysis , 2016, Scientific Reports.
[12] Richard A. White,et al. Risk Factors for Sporadic Domestically Acquired Campylobacter Infections in Norway 2010–2011: A National Prospective Case-Control Study , 2015, PloS one.
[13] Neal J. Golden,et al. Temporal patterns of Campylobacter contamination on chicken and their relationship to campylobacteriosis cases in the United States. , 2015, International journal of food microbiology.
[14] Si Ming Man,et al. Global Epidemiology of Campylobacter Infection , 2015, Clinical Microbiology Reviews.
[15] P. Teunis,et al. Campylobacter seroconversion rates in selected countries in the European Union , 2012, Epidemiology and Infection.
[16] L. Matthews,et al. Identifying the seasonal origins of human campylobacteriosis , 2012, Epidemiology and Infection.
[17] N. French,et al. Risk Factors for Campylobacteriosis of Chicken, Ruminant, and Environmental Origin: A Combined Case-Control and Source Attribution Analysis , 2012, PloS one.
[18] Christophe Sarran,et al. Campylobacter epidemiology: a descriptive study reviewing 1 million cases in England and Wales between 1989 and 2011 , 2012, BMJ Open.
[19] Keith A. Jolley,et al. A Gene-By-Gene Approach to Bacterial Population Genomics: Whole Genome MLST of Campylobacter , 2012, Genes.
[20] T. Hald,et al. Source attribution of human campylobacteriosis using a meta-analysis of case-control studies of sporadic infections , 2012, Epidemiology and Infection.
[21] Laura C Rodrigues,et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice , 2011, Gut.
[22] P. Godoy,et al. Case-control study of risk factors for sporadic Campylobacter infections in northeastern Spain. , 2010, European journal of public health.
[23] Louise Matthews,et al. Geographic determinants of reported human Campylobacter infections in Scotland , 2010, BMC public health.
[24] R. M. Sulc,et al. Analysis of Herbage Mass and Herbage Accumulation Rate Using Gompertz Equations , 2010 .
[25] Y. V. van Duynhoven,et al. Risk factors for indigenous Campylobacter jejuni and Campylobacter coli infections in The Netherlands: a case-control study , 2010, Epidemiology and Infection.
[26] S. Walz,et al. Assessment of the Duration of Protection in Campylobacter jejuni Experimental Infection in Humans , 2010, Infection and Immunity.
[27] S. Sheppard,et al. Campylobacter excreted into the environment by animal sources: prevalence, concentration shed, and host association. , 2009, Foodborne pathogens and disease.
[28] L. Rodrigues,et al. Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors for Campylobacter Enteritis, England , 2009, Emerging infectious diseases.
[29] S. Sheppard,et al. Spatiotemporal Homogeneity of Campylobacter Subtypes from Cattle and Sheep across Northeastern and Southwestern Scotland , 2009, Applied and Environmental Microbiology.
[30] W. van Pelt,et al. Immunity to Campylobacter: its role in risk assessment and epidemiology , 2009, Critical reviews in microbiology.
[31] D. Tompkins,et al. Demographic determinants for Campylobacter infection in England and Wales: implications for future epidemiological studies , 2008, Epidemiology and Infection.
[32] Arie H Havelaar,et al. A Risk Assessment Model for Campylobacter in Broiler Meat , 2007, Risk analysis : an official publication of the Society for Risk Analysis.
[33] M. Iturriza-Gómara,et al. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993–1996) , 2007, European Journal of Clinical Microbiology & Infectious Diseases.
[34] G. Ruiz-Palacios. The health burden of Campylobacter infection and the impact of antimicrobial resistance: playing chicken. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] A. Charlett,et al. Foreign and domestic travel and the risk of Campylobacter infection: results from a population-based sentinel surveillance scheme. , 2003, Journal of travel medicine.
[36] J. Hanley,et al. Statistical analysis of correlated data using generalized estimating equations: an orientation. , 2003, American journal of epidemiology.
[37] D. Vose. Risk Analysis: A Quantitative Guide , 2000 .
[38] D. Wareing,et al. Campylobacter contamination of raw meat and poultry at retail sale: identification of multiple types and comparison with isolates from human infection. , 2000, Journal of food protection.
[39] J. S. Wallace,et al. The seasonal variation of thermophilic campylobacters in beef cattle, dairy cattle and calves , 1998, Journal of applied microbiology.
[40] R. Slack,et al. The autumn peak in campylobacter gastro-enteritis. Are the risk factors the same for travel- and UK-acquired campylobacter infections? , 1995, Journal of public health medicine.
[41] M. Blaser,et al. Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand , 1988, Journal of clinical microbiology.
[42] M. Blaser,et al. Experimental Campylobacter jejuni infection in humans. , 1988, The Journal of infectious diseases.
[43] Campylobacter contamination in fresh whole chilled UK-produced chickens at retail : August – December 2016 , 2017 .
[44] STATUS OF IN , 2000 .